The Enterprise Value as of September 2024 (TTM) for Acasti Pharma Inc. (ACST) is 6.77M

According to Acasti Pharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.77M. This represents a change of -11.98% compared to the average of 7.69M of the last 4 quarters.

Acasti Pharma Inc. (ACST) Historical Enterprise Value (quarterly & annually)

How has ACST Enterprise Value performed in the past?

The mean historical Enterprise Value of Acasti Pharma Inc. over the last ten years is 72.63M. The current 6.77M Enterprise Value has changed 831.67% with respect to the historical average. Over the past ten years (40 quarters), ACST's Enterprise Value was at its highest in in the December 2019 quarter at 257.67M. The Enterprise Value was at its lowest in in the March 2019 quarter at -15506292.00.

Acasti Pharma Inc. (ACST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Acasti Pharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acasti Pharma Inc. (ACST) Average Enterprise Value

How has ACST Enterprise Value performed in the past?

The current Enterprise Value of Acasti Pharma Inc. (ACST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Acasti Pharma Inc. (ACST) Enterprise Value vs. Peers

How is ACST’s Enterprise Value compared to its peers?

Acasti Pharma Inc.’s Enterprise Value is less than Tonix Pharmaceuticals Holding Corp. (8.34M), less than Jaguar Health, Inc. (28.36M), greater than Diffusion Pharmaceuticals Inc. (-1447403.00), less than iBio, Inc. (27.80M), greater than Aridis Pharmaceuticals, Inc. (1.44M), less than Akari Therapeutics, Plc (38.48M), less than Aditxt, Inc. (10.42M), less than ABVC BioPharma, Inc. (10.50M), greater than Pulmatrix, Inc. (-6324963.00), greater than Onconova Therapeutics, Inc. (4.51M), less than Catalyst Biosciences, Inc. (19.42M), greater than Bio-Path Holdings, Inc. (-1337813.00), greater than Moleculin Biotech, Inc. (-3599909.00), greater than Advaxis, Inc. (4.29M), less than GeoVax Labs, Inc. (21.42M), less than Ocugen, Inc. (330.84M),

Build a custom stock screener for Acasti Pharma Inc. (ACST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acasti Pharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acasti Pharma Inc. (ACST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acasti Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.